FY2026 Earnings Forecast for Geron Co. Issued By B. Riley (NASDAQ:GERN)

Geron Co. (NASDAQ:GERN – Get Rating) – Research analysts at B. Riley decreased their FY2026 earnings per share estimates for Geron in a note issued to investors on Friday, May 12th. B. Riley analyst K. Patel now expects that the biopharmaceutical company will earn $0.07 per share for the year, down from their previous estimate […]

Related Keywords

V Bryan Lawlis ,Goldman Sachs Group ,Cerity Partners ,Geron Corp ,Omnistar Financial Group Inc ,Nasdaq ,Nisa Investment Advisors ,Geron Co ,Asset Management Inc ,Securities Exchange Commission ,Needham Company ,Get Rating ,Trading Down ,Star Financial Group ,Valley Asset Management Partners ,Investment Advisors ,Management Inc ,Directorv Bryan Lawlis ,Exchange Commission ,Foster City ,Geron Daily ,Orgeron ,Nasdaq Gern ,Egern ,Medical ,37416310 ,Earnings Estimates ,B Riley ,